Does ECULIZUMAB Cause Haemoglobin decreased? 3,028 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,028 reports of Haemoglobin decreased have been filed in association with ECULIZUMAB (SOLIRIS). This represents 6.9% of all adverse event reports for ECULIZUMAB.
3,028
Reports of Haemoglobin decreased with ECULIZUMAB
6.9%
of all ECULIZUMAB reports
127
Deaths
1,045
Hospitalizations
How Dangerous Is Haemoglobin decreased From ECULIZUMAB?
Of the 3,028 reports, 127 (4.2%) resulted in death, 1,045 (34.5%) required hospitalization, and 45 (1.5%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 3,028 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
Malaise (1,562)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
RIVAROXABAN (1,709)
Which ECULIZUMAB Alternatives Have Lower Haemoglobin decreased Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB